For: | Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol 2013; 2(2): 38-43 [PMID: 24175264 DOI: 10.5527/wjn.v2.i2.38] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v2/i2/38.htm |
Number | Citing Articles |
1 |
Driton Vela. Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology. BioFactors 2019; 45(2): 118 doi: 10.1002/biof.1468
|
2 |
Rengin Elsurer Afsar, Mehmet Kanbay, Avsin Ibis, Baris Afsar. In-depth review: is hepcidin a marker for the heart and the kidney?. Molecular and Cellular Biochemistry 2021; 476(9): 3365 doi: 10.1007/s11010-021-04168-4
|
3 |
Norishi Ueda, Kazuya Takasawa. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease. Nutrients 2018; 10(9): 1173 doi: 10.3390/nu10091173
|
4 |
Kankokaran Vadakkeveetil Anupama, Manjusha Yadla. Serum hepcidin levels and cardiovascular outcomes in patients on maintenance hemodialysis. Journal of The Egyptian Society of Nephrology and Transplantation 2022; 22(4): 209 doi: 10.4103/jesnt.jesnt_20_21
|
5 |
Rachel P. L. van Swelm, Jack F. M. Wetzels, Dorine. W. Swinkels. The multifaceted role of iron in renal health and disease. Nature Reviews Nephrology 2020; 16(2): 77 doi: 10.1038/s41581-019-0197-5
|
6 |
Driton Vela. Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology. Laboratory Investigation 2018; 98(3): 315 doi: 10.1038/labinvest.2017.111
|
7 |
Yao-Peng Hsieh, Ching-Hui Huang, Chia-Ying Lee, Ching-Yuang Lin, Chia-Chu Chang. Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes. Journal of Occupational Medicine and Toxicology 2014; 9(1) doi: 10.1186/1745-6673-9-11
|
8 |
Lucia Del Vecchio, Francesco Locatelli. New treatment approaches in chronic kidney disease-associated anaemia. Expert Opinion on Biological Therapy 2014; 14(5): 687 doi: 10.1517/14712598.2014.892577
|